Citigroup has a negative outlook on the stock price of Applied Therapeutics (NASDAQ: APLT).

Citigroup reduced their price target on shares of Applied Therapeutics from $13.00 to $8.00 and set a “buy” rating for the company in a report on Friday…

Read More: https://www.marketbeat.com/instant-alerts/citigroup-issues-pessimistic-forecast-for-applied-therapeutics-nasdaqaplt-stock-price-2024-11-29/